Autoimmunity to citrullinated proteins and the initiation of rheumatoid arthritis.

Clinical manifestations of rheumatoid arthritis (RA), the second most common human autoimmune disease, are primarily focused on the joints, causing disability and requiring life-long treatment to ameliorate signs and symptoms. The etiology of RA is unknown; however, important discoveries in two areas have been made which provide hope that the causal mechanisms can be identified. First, the most severe form of this disease is associated with the presence of humoral and cellular autoimmunity to citrullinated proteins and peptides. Second, in the natural history of RA, autoimmunity to citrullinated antigens appears years before the onset of clinically apparent disease. Herein is described a model in which to consider how these two features are linked during very early disease development.

[1]  A. Wiik,et al.  Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case–control study nested in a cohort of Norwegian blood donors , 2007, Annals of the rheumatic diseases.

[2]  J. Hazes,et al.  The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. , 2000, Arthritis and rheumatism.

[3]  L. Trouw,et al.  Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways. , 2009, Arthritis and rheumatism.

[4]  L. Alfredsson,et al.  Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile , 2012, Annals of the rheumatic diseases.

[5]  J. Rocklöv,et al.  Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis. , 2010, Arthritis and rheumatism.

[6]  Göran Hallmans,et al.  Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. , 2003, Arthritis and rheumatism.

[7]  P. Gregersen,et al.  Multiple cytokines and chemokines are associated with rheumatoid arthritis-related autoimmunity in first-degree relatives without rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA) , 2012, Annals of the rheumatic diseases.

[8]  F. V. D. van den Hoogen,et al.  Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. , 1998, The Journal of clinical investigation.

[9]  J. Drijfhout,et al.  Anti-citrullinated protein antibodies have a low avidity compared with antibodies against recall antigens , 2010, Annals of the rheumatic diseases.

[10]  R. Cole,et al.  Autocitrullination of human peptidyl arginine deiminase type 4 regulates protein citrullination during cell activation. , 2010, Arthritis and rheumatism.

[11]  Y. Alamanos,et al.  Pulmonary involvement in patients with early rheumatoid arthritis , 2007, Scandinavian journal of rheumatology.

[12]  L. Alfredsson,et al.  Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis. , 2011, Seminars in immunology.

[13]  T. Huizinga,et al.  Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage , 2011, Proceedings of the National Academy of Sciences.

[14]  R Hal Scofield,et al.  Development of autoantibodies before the clinical onset of systemic lupus erythematosus. , 2003, The New England journal of medicine.

[15]  P. Tak,et al.  Hunting for the pathogenesis of rheumatoid arthritis: core-needle biopsy of inguinal lymph nodes as a new research tool , 2012, Annals of the rheumatic diseases.

[16]  L. Klareskog,et al.  Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity , 2005, Arthritis research & therapy.

[17]  N. Gt,et al.  Prediction of susceptibility to rheumatoid arthritis by human leukocyte antigen genotyping. , 1992 .

[18]  A. Purcell,et al.  T-cell autoreactivity to citrullinated autoantigenic peptides in rheumatoid arthritis patients carrying HLA-DRB1 shared epitope alleles , 2012, Arthritis Research & Therapy.

[19]  P. Gregersen,et al.  Prevention of autoimmune rheumatic disease: state of the art and future perspectives , 2010, Annals of the rheumatic diseases.

[20]  Göran Hallmans,et al.  Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis , 2011, Arthritis research & therapy.

[21]  G. Firestein,et al.  Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis , 2012, Nature Reviews Rheumatology.

[22]  J. Manson,et al.  Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies. , 2009, Arthritis and rheumatism.

[23]  W. Robinson,et al.  Immune Complexes Containing Citrullinated Fibrinogen Costimulate Macrophages via Toll-like Receptor 4 and Fc Receptor , 2010 .

[24]  T. Huizinga,et al.  Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid. , 2010, Arthritis and rheumatism.

[25]  M. Weinblatt,et al.  Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis. , 2010, Arthritis and rheumatism.

[26]  D. Lynch,et al.  Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity? , 2012, Arthritis and rheumatism.

[27]  P. Gregersen,et al.  Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk of rheumatoid arthritis. , 2012, Arthritis and rheumatism.

[28]  B. Dijkmans,et al.  Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase , 2010, Annals of the rheumatic diseases.

[29]  P. Gregersen,et al.  Relatives without rheumatoid arthritis show reactivity to anti-citrullinated protein/peptide antibodies that are associated with arthritis-related traits: studies of the etiology of rheumatoid arthritis. , 2013, Arthritis and rheumatism.

[30]  R. Tibshirani,et al.  Autoantibody Epitope Spreading in the Pre-Clinical Phase Predicts Progression to Rheumatoid Arthritis , 2012, PloS one.

[31]  L. Alfredsson,et al.  Immunity to citrullinated proteins in rheumatoid arthritis. , 2008, Annual review of immunology.

[32]  J. Stéen,et al.  Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition , 2013, The Journal of experimental medicine.

[33]  M. Weinblatt,et al.  Sustained rheumatoid arthritis remission is uncommon in clinical practice , 2012, Arthritis Research & Therapy.

[34]  R. Wait,et al.  Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis. , 2010, Arthritis and rheumatism.

[35]  T. Huizinga,et al.  Genetics of rheumatoid arthritis: what have we learned? , 2011, Immunogenetics.

[36]  K. Deane,et al.  Treatment Strategies in Early Rheumatoid Arthritis and Prevention of Rheumatoid Arthritis , 2012, Current Rheumatology Reports.

[37]  Polly Matzinger,et al.  Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses , 2004, Nature Reviews Immunology.

[38]  H. Schumacher,et al.  Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset , 2000, Arthritis research.

[39]  Felipe Andrade,et al.  Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis , 2011, Annals of the rheumatic diseases.

[40]  L. Alfredsson,et al.  A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. , 2004, Arthritis and rheumatism.

[41]  I. Bekeredjian-Ding,et al.  Toll‐like receptors – sentries in the B‐cell response , 2009, Immunology.

[42]  P. Toivanen,et al.  Fecal microbiota in early rheumatoid arthritis. , 2008, The Journal of rheumatology.

[43]  Christophe Benoist,et al.  Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. , 2010, Immunity.

[44]  Bonnie Bruce,et al.  Antigen microarray profiling of autoantibodies in rheumatoid arthritis. , 2005, Arthritis and rheumatism.

[45]  J. Murray,et al.  Celiac disease and autoimmunity in the gut and elsewhere. , 2008, Gastroenterology clinics of North America.

[46]  D. van Schaardenburg,et al.  Avidity maturation of anti-citrullinated protein antibodies in rheumatoid arthritis. , 2012, Arthritis and rheumatism.

[47]  W. Robinson,et al.  Autoimmunity against Fibrinogen Mediates Inflammatory Arthritis in Mice , 2009, The Journal of Immunology.

[48]  A. Vissink,et al.  Periodontitis in established rheumatoid arthritis patients: a cross-sectional clinical, microbiological and serological study , 2012, Arthritis Research & Therapy.

[49]  K. Deane,et al.  Antibodies to Citrullinated Protein Antigens (ACPAs): Clinical and Pathophysiologic Significance , 2011, Current rheumatology reports.

[50]  G. Hallmans,et al.  Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis. , 2013, Arthritis and rheumatism.

[51]  W. Robinson,et al.  Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice , 2008, The Journal of experimental medicine.

[52]  J. Norris,et al.  Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease. , 2013, Arthritis and rheumatism.

[53]  L. Alfredsson,et al.  A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. , 2006, Arthritis and rheumatism.

[54]  Lars Alfredsson,et al.  Specific interaction between genotype, smoking and autoimmunity to citrullinated α-enolase in the etiology of rheumatoid arthritis , 2009, Nature Genetics.

[55]  A. Silman,et al.  Epidemiology of rheumatoid arthritis , 1994, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[56]  Steven J. Schrodi,et al.  A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. , 2004, American journal of human genetics.

[57]  Annette Lee,et al.  Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis , 2008, Arthritis research & therapy.

[58]  M. Gaxiola,et al.  Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. , 2006, The Journal of clinical investigation.

[59]  C. Lewis,et al.  EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis , 2012, Annals of the rheumatic diseases.

[60]  J. O'dell,et al.  Citrullinated mouse collagen administered to DBA/1J mice in the absence of adjuvant initiates arthritis. , 2012, International immunopharmacology.

[61]  L. Barra,et al.  Anti-citrullinated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients. , 2013, Arthritis and rheumatism.

[62]  M. Jolivet,et al.  The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. , 1999, Journal of immunology.

[63]  J. Drijfhout,et al.  Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive patients with rheumatoid arthritis. , 2010, Arthritis and rheumatism.

[64]  Pojen P. Chen,et al.  NETs Are a Source of Citrullinated Autoantigens and Stimulate Inflammatory Responses in Rheumatoid Arthritis , 2013, Science Translational Medicine.

[65]  J. Gebe,et al.  Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1*0401-positive humanized mice and rheumatoid arthritis patients. , 2011, Arthritis and rheumatism.

[66]  T. Huizinga,et al.  The influence of ACPA status and characteristics on the course of RA , 2012, Nature Reviews Rheumatology.

[67]  J. Norris,et al.  Preclinical rheumatoid arthritis: identification, evaluation, and future directions for investigation. , 2010, Rheumatic diseases clinics of North America.

[68]  M. Newkirk Rheumatoid factors: what do they tell us? , 2002, The Journal of rheumatology.

[69]  P. Thompson,et al.  The protein arginine deiminases: Structure, function, inhibition, and disease. , 2013, Biopolymers.

[70]  E. Karlson,et al.  Environmental and gene-environment interactions and risk of rheumatoid arthritis. , 2012, Rheumatic diseases clinics of North America.

[71]  C. Bernstein,et al.  Familial clustering of the serum cytokine profile in the relatives of rheumatoid arthritis patients. , 2012, Arthritis and rheumatism.

[72]  J. Norris,et al.  The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner. , 2010, Arthritis and rheumatism.

[73]  M. Sebbag,et al.  Fcγ receptor profile of monocytes and macrophages from rheumatoid arthritis patients and their response to immune complexes formed with autoantibodies to citrullinated proteins , 2011, Annals of the rheumatic diseases.

[74]  Noel R Rose,et al.  Autoimmune thyroiditis and ROS. , 2008, Autoimmunity reviews.

[75]  Kutty Selva Nandakumar,et al.  Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis , 2009, The Journal of experimental medicine.

[76]  R. Toes,et al.  Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. , 2012, The Journal of clinical investigation.

[77]  W. Robinson,et al.  Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. , 2006, The Journal of clinical investigation.

[78]  K. Haskins,et al.  A Citrullinated Fibrinogen-Specific T Cell Line Enhances Autoimmune Arthritis in a Mouse Model of Rheumatoid Arthritis , 2013, The Journal of Immunology.

[79]  V. Holers,et al.  Can we accurately predict the development of rheumatoid arthritis in the preclinical phase? , 2003, Arthritis and rheumatism.

[80]  A. Viale,et al.  Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. , 2012, Arthritis and rheumatism.

[81]  B. Dijkmans,et al.  Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. , 2004, Arthritis and rheumatism.

[82]  G. Eisenbarth,et al.  Diagnosis and treatment of pre-insulin dependent diabetes. , 1998, Annual review of medicine.